GlassScriptPhysician profile
Val Prokurat
NPI 1316109366
$4,428.15
in general payments reported to CMS, 2019-2025
26 companies · $129 in 2025
The $129 reported for 2025 was less than what a typical Surgery provider received nationally (typical 2025 total: $281).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,159 · 2020: $78.53 · 2021: $467 · 2022: $573 · 2023: $707 · 2024: $315 · 2025: $129.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,118 · Education: $32.27.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,118.04 |
| Education | $32.27 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $2,187.69 | 2019-2025 | Da Vinci Surgical System |
| Novo Nordisk INC | $539.13 | 2019-2025 | Wegovy, Saxenda |
| Baxter Healthcare | $255.30 | 2019-2023 | Tisseel, Floseal |
| Teleflex LLC | $239.01 | 2023 | Deknatel, Weck, Titan Sgs Standard Gastric Stapler |
| W. L. Gore & Associates, INC. | $141.68 | 2021 | |
| Endo Pharmaceuticals INC. | $139.28 | 2021-2024 | Nascobal |
| Davol INC. | $123.08 | 2019-2022 | |
| Ethicon US, LLC | $114.93 | 2019-2024 | Stratafix, Harmonic |
| Lilly USA, LLC | $78.16 | 2024-2025 | Zepbound |
| Integra Lifesciences Corporation | $78.10 | 2023-2025 | Integra, Integra Dermal Regeneration Template, Surgimend |
| Standard Bariatrics, INC. | $69.55 | 2022 | |
| Kerecis Limited | $63.07 | 2020-2022 | |
| Intra-Sana Laboratories | $58.74 | 2022-2024 | Reltone 400 Mg, Reltone 200 Mg, Glycate |
| Conmed Corporation | $55.56 | 2019 | |
| Tela Bio, INC. | $47.69 | 2023-2024 | Ovitex Reinforced Bioscaffold With Permanent Polymer (Ovitex), Ovitex 2s |
Show all 26 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Laborie Medical Technologies Corp. | $43.65 | 2024 | |
| Phathom Pharmaceuticals, INC. | $34.67 | 2024-2025 | Voquezna |
| Acera Surgical, INC. | $29.09 | 2022 | |
| Avanos Medical | $23.56 | 2019 | |
| Olympus America INC. | $17.83 | 2021 | |
| Innocoll Pharmaceuticals Limited | $17.70 | 2021 | |
| Lsi Solutions INC | $15.93 | 2024 | Cor-Knot |
| Endogastric Solutions, INC | $15.53 | 2024 | Esophyx |
| Acell, INC. | $14.20 | 2020 | |
| Shire North American Group INC | $12.55 | 2019 | |
| Pacira Pharmaceuticals Incorporated | $12.47 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Val Prokurat listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.